Patents Examined by Frederick Kross
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6977250
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: December 20, 2005
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez